Haematology & Oncology Prometric exam questions with answers
15 original practice questions written to the Haematology & Oncology exam blueprint, each with the answer and why the other options are wrong. Below them: the Haematology & Oncology exam's format, pass mark and fee at DHA, DOH, MOHAP, SHA, SCFHS, QCHP, NHRA, OMSB and Kuwait MOH, from their own published rules.
- 15
- Free questions
- 2
- Regulators publish this exam
- 65%
- Pass marks by regulator
- 12
- Questions in the free mock
Quick answer
The Haematology & Oncology exam is 200 MCQs in 240 minutes at SCFHS (pass mark 65%) and 150 MCQs in 3 hours at QCHP (pass mark 65%). Below are 15 original practice questions written to the official blueprint, each with the answer and why the other options are wrong, plus a free 12-question timed mock.
The full Haematology & Oncology bank: from 3 papers, ~150 questions each
AED 319 one-time
Every question with a rationale and a reference. PDF, lifetime access.
Tell us your authority and we send the bank for that exam, usually the same day.
The Haematology & Oncology exam in every GCC country
SCFHS, QCHP publish an exact Haematology & Oncology exam; the others apply one format to every title. Figures come from each regulator's own exam pages - anything not published says so.
| Regulator | Exam | Format | Pass mark | Fee per attempt |
|---|---|---|---|---|
Saudi Classification Examination - Hematology and Oncology | 200 MCQs in 240 minutes | 65% | Not published | |
Specialist Haematology and Oncology | 150 MCQs in 3 hours | 65% | Not published | |
No exam published for this title Not in the DHA CBT list; DHA's guideline assesses licensed titles that are not listed by oral | Not published | Not published | Not published | |
No written exam published Oral assessment, 45-60 minutes; no written exam (DOH Licensing Procedure Manual 2024) | Panel / review | Not published | Not published | |
No exam published for this title MOHAP publishes no exam for this title that we could find; check with MOHAP | Not published | Not published | Not published | |
No exam published for this title SHA publishes no exam for this title that we could find; check with SHA | Not published | Not published | Not published | |
No exam published for this title NHRA publishes no exam for this title that we could find; check with NHRA | Not published | Not published | Not published | |
No exam published for this title No OMSB exam published for this title; check with OMSB | Not published | Not published | Not published | |
No exam published for this title Kuwait MOH publishes no exam for this title; check with the MOH | Not published | Not published | Not published |
Highlighted rows publish figures for this exact Haematology & Oncology exam; the others show the regulator's general rules.
Pass marks, attempts and fees change - confirm yours on the regulator's exam page before you book.
15 Haematology & Oncology exam questions with answers
Choose your answer first, then open the explanation. The set covers the main blueprint domains at a mix of easy, medium and hard.
- Question 1Haemoglobinopathies and Transfusion Medicinemedium
A young adult with sickle cell disease admitted with a painful crisis develops fever, chest pain, falling oxygen saturation of 89% on air and a new infiltrate on chest radiograph. Besides oxygen and antibiotics, what is the key treatment?
- AHigh-dose opioids alone
- BBlood transfusion, simple or exchange
- CIntravenous furosemide
- DStart hydroxyurea immediately
Show answer and explanation
Answer: B. Blood transfusion, simple or exchange
This is acute chest syndrome, a leading cause of death in sickle cell disease. Hypoxia or deterioration is an indication for transfusion, with exchange transfusion for severe disease, alongside oxygen, antibiotics covering atypical organisms, analgesia and incentive spirometry. Hydroxyurea prevents future episodes but does not treat the acute event.
Reference: BSH Guideline on the management of acute chest syndrome in sickle cell disease, 2015
- Question 2Haemoglobinopathies and Transfusion Medicinehard
Which patient most clearly needs irradiated cellular blood components to prevent transfusion-associated graft-versus-host disease?
- AA patient with Hodgkin lymphoma
- BA patient with iron deficiency anaemia
- CA patient with sickle cell trait
- DA patient receiving warfarin
Show answer and explanation
Answer: A. A patient with Hodgkin lymphoma
Patients with Hodgkin lymphoma at any stage need irradiated components, as do those treated with purine analogues such as fludarabine and recipients of stem cell transplants. Irradiation inactivates donor lymphocytes that could cause fatal graft-versus-host disease. Iron deficiency, sickle trait and warfarin are not indications.
Reference: Foukaneli et al., BSH Guidelines on the use of irradiated blood components, Br J Haematol 2020
- Question 3Lymphoid Malignancies and Plasma Cell Disordersmedium
A 68-year-old has a lymphocyte count of 25 x 10^9/L with smudge cells. Flow cytometry shows CD5 and CD23 positive B cells. He has no symptoms, cytopenias or bulky nodes. What is the most appropriate management?
- AStart a BTK inhibitor now
- BStart chemoimmunotherapy now
- CRefer for allogeneic transplant
- DActive monitoring without treatment
Show answer and explanation
Answer: D. Active monitoring without treatment
Early-stage asymptomatic chronic lymphocytic leukaemia is managed by watch and wait, as early treatment has not improved survival. Treatment is indicated for active disease such as progressive marrow failure, symptomatic nodes or spleen, constitutional symptoms or rapid lymphocyte doubling. Transplant is reserved for selected high-risk relapsed disease.
Reference: Hallek et al., iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL, Blood 2018
- Question 4Myeloid Malignanciesmedium
A 40-year-old has bleeding gums, a low fibrinogen, raised D-dimer and abnormal promyelocytes with multiple Auer rods on the blood film. What is the most important immediate step?
- AWait for genetic confirmation before any treatment
- BStart all-trans retinoic acid at once
- CGive heparin to treat the coagulopathy
- DPerform an urgent splenectomy
Show answer and explanation
Answer: B. Start all-trans retinoic acid at once
Suspected acute promyelocytic leukaemia is an emergency because of life-threatening coagulopathy. All-trans retinoic acid should start as soon as the diagnosis is suspected, without waiting for PML-RARA confirmation, together with aggressive blood product support. Early deaths are mainly from haemorrhage.
Reference: Sanz et al., Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet, Blood 2019
- Question 5Red Cell Disorders and Anaemiaseasy
A 34-year-old woman with heavy periods has haemoglobin 92 g/L, MCV 71 fL and a normal CRP. Which single test best confirms iron deficiency?
- ASerum ferritin
- BSerum iron
- CHaemoglobin electrophoresis
- DReticulocyte count
Show answer and explanation
Answer: A. Serum ferritin
A low serum ferritin is the most specific test for iron deficiency, especially when inflammation is absent. Serum iron fluctuates widely and is unreliable alone. Haemoglobin electrophoresis is used for suspected thalassaemia when ferritin is normal.
Reference: BSH Guideline for the laboratory diagnosis of iron deficiency in adults, 2021
- Question 6Myeloid Malignanciesmedium
On day 8 of all-trans retinoic acid for acute promyelocytic leukaemia, a patient develops fever, weight gain, breathlessness and pulmonary infiltrates. What is the most appropriate treatment?
- ADexamethasone 10 mg twice daily
- BBroad-spectrum antibiotics only
- CDouble the dose of retinoic acid
- DIntravenous furosemide only
Show answer and explanation
Answer: A. Dexamethasone 10 mg twice daily
These features suggest differentiation syndrome, which is treated promptly with dexamethasone 10 mg twice daily, with temporary interruption of the differentiating agent if severe. Antibiotics may be given if infection is possible but do not treat the syndrome. Increasing retinoic acid would worsen it.
Reference: Sanz et al., Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet, Blood 2019
- Question 7Solid Tumour Oncologyhard
A man has orchidectomy for a testicular mass, and histology reports pure seminoma. His serum AFP is clearly raised. How should this be interpreted?
- AIt is typical of pure seminoma
- BIt suggests a hepatoma unrelated to the testis
- CIt indicates non-seminomatous elements
- DIt is a laboratory error to be ignored
Show answer and explanation
Answer: C. It indicates non-seminomatous elements
Pure seminoma does not produce AFP, so a raised AFP indicates non-seminomatous elements such as yolk sac tumour, and the patient should be managed as non-seminomatous germ cell tumour. Beta-hCG can be mildly raised in seminoma. Other causes of raised AFP should be excluded, but the result should not be ignored.
Reference: EAU Guidelines on Testicular Cancer
- Question 8Systemic Anticancer Therapy and Supportive Careeasy
Ten days after chemotherapy, a patient has a temperature of 38.5 degrees Celsius and a neutrophil count of 0.3 x 10^9/L. He is haemodynamically stable. What is the most important immediate action?
- AWait for blood culture results before treating
- BGive oral paracetamol and review in 4 hours
- CStart empirical IV broad-spectrum antibiotics within 1 hour
- DGive granulocyte colony-stimulating factor only
Show answer and explanation
Answer: C. Start empirical IV broad-spectrum antibiotics within 1 hour
Neutropenic sepsis is a medical emergency, and empirical intravenous broad-spectrum antibiotics such as piperacillin-tazobactam should be given within 1 hour of presentation after cultures are taken. Delay increases mortality. G-CSF is not a substitute for antibiotics.
Reference: NICE Clinical Guideline CG151: Neutropenic sepsis
Halfway - how are you scoring?
Test yourself under real exam conditions
The free 12-question mock is timed and scored against the pass mark, domain by domain, so you see exactly where you are losing marks. The full Haematology & Oncology bank starts at 3 full-length papers of about 150 questions each for AED 319, one-time, and you can add papers up to 6.
Tell us your authority and we send the bank for that exam, usually the same day.
- Question 9Red Cell Disorders and Anaemiasmedium
A 70-year-old has macrocytic anaemia, numb feet and impaired vibration sense. Both serum B12 and folate are low. What is the correct order of replacement?
- AFolic acid first, then B12 after 2 weeks
- BFolic acid alone, as neuropathy is unrelated
- CStart B12 before or with folic acid
- DOral iron first, then both vitamins
Show answer and explanation
Answer: C. Start B12 before or with folic acid
When both are deficient, B12 should be started before or together with folic acid, because folate alone can correct the anaemia while allowing neurological damage such as subacute combined degeneration to progress. Neurological signs indicate the need for intensive intramuscular B12. Iron is not indicated without iron deficiency.
Reference: BSH Guidelines for the diagnosis and treatment of cobalamin and folate disorders, 2014
- Question 10Red Cell Disorders and Anaemiasmedium
A patient with active rheumatoid arthritis has normocytic anaemia, ferritin 450 micrograms/L, low transferrin saturation and raised CRP. What mechanism mainly explains the anaemia?
- ARaised hepcidin restricting iron release
- BAutoimmune destruction of red cells
- CLoss of iron from the gut
- DDeficient erythropoietin from kidney failure
Show answer and explanation
Answer: A. Raised hepcidin restricting iron release
In anaemia of inflammation, cytokines such as IL-6 increase hepcidin, which blocks iron release from macrophages and gut absorption, giving low transferrin saturation with normal or high ferritin. Gut iron loss would give a low ferritin. Haemolysis would raise reticulocytes and bilirubin.
Reference: Weiss, Ganz and Goodnough, Anemia of inflammation, Blood 2019
- Question 11Solid Tumour Oncologymedium
A non-smoker has metastatic lung adenocarcinoma with an EGFR exon 19 deletion. What is the preferred first-line systemic treatment?
- APlatinum doublet chemotherapy
- BPembrolizumab monotherapy
- COsimertinib
- DCrizotinib
Show answer and explanation
Answer: C. Osimertinib
Osimertinib, a third-generation EGFR tyrosine kinase inhibitor, improved survival over earlier EGFR inhibitors in first-line treatment of EGFR-mutant NSCLC. Immunotherapy alone is less effective in EGFR-mutant disease. Crizotinib targets ALK and ROS1 rearrangements.
Reference: Ramalingam et al., Overall survival with osimertinib in untreated EGFR-mutated advanced NSCLC (FLAURA), N Engl J Med 2020
- Question 12Solid Tumour Oncologymedium
A postmenopausal woman with ER-positive early breast cancer is starting adjuvant letrozole. Which baseline assessment is most important?
- ABone mineral density scan
- BRetinal examination
- CAudiometry
- DPulmonary function tests
Show answer and explanation
Answer: A. Bone mineral density scan
Aromatase inhibitors lower oestrogen further and accelerate bone loss, so baseline bone density assessment, calcium and vitamin D, and bisphosphonates where indicated are recommended. Tamoxifen has different risks, including thromboembolism and endometrial cancer. Audiometry relates to platinum drugs.
Reference: ESMO Clinical Practice Guideline: Early Breast Cancer, 2024
- Question 13Stem Cell Transplantation and Professional Practicemedium
Three weeks after allogeneic stem cell transplant, a patient develops a rash on the palms and soles, diarrhoea and raised bilirubin. Which condition do these three organ systems most suggest?
- AAcute graft-versus-host disease
- BEngraftment failure
- CCytomegalovirus retinitis
- DVeno-occlusive disease alone
Show answer and explanation
Answer: A. Acute graft-versus-host disease
Acute graft-versus-host disease classically affects the skin, gastrointestinal tract and liver, with rash often starting on the palms and soles. Veno-occlusive disease causes jaundice, painful hepatomegaly and fluid retention but not the rash and diarrhoea. Biopsy and exclusion of infection support the diagnosis before systemic steroids.
Reference: Penack et al., Prophylaxis and management of graft versus host disease after stem-cell transplantation: EBMT recommendations, Lancet Haematol 2020
- Question 14Systemic Anticancer Therapy and Supportive Caremedium
Which chemotherapy drug is best known for cumulative dose-related cardiomyopathy, so that lifetime dose must be recorded?
- AVincristine
- BDoxorubicin
- CCisplatin
- DMethotrexate
Show answer and explanation
Answer: B. Doxorubicin
Anthracyclines such as doxorubicin cause cardiomyopathy whose risk rises with cumulative dose, so lifetime exposure is tracked and cardiac function monitored. Vincristine causes neuropathy and cisplatin nephrotoxicity and ototoxicity. Methotrexate toxicity includes mucositis and myelosuppression.
Reference: Lyon et al., 2022 ESC Guidelines on cardio-oncology, Eur Heart J 2022
- Question 15Systemic Anticancer Therapy and Supportive Caremedium
A patient is to receive high-dose cisplatin. Which antiemetic combination is recommended as prophylaxis for this highly emetogenic regimen?
- AMetoclopramide and domperidone as needed
- BOndansetron and dexamethasone only
- CDexamethasone and lorazepam only
- DNK1 and 5-HT3 antagonists, dexamethasone, olanzapine
Show answer and explanation
Answer: D. NK1 and 5-HT3 antagonists, dexamethasone, olanzapine
For highly emetogenic chemotherapy such as cisplatin, guidelines recommend a four-drug regimen combining an NK1 receptor antagonist, a 5-HT3 antagonist, dexamethasone and olanzapine. Single agents give poor control of acute and delayed vomiting. Uncontrolled vomiting can cause dehydration and worsen cisplatin nephrotoxicity.
Reference: Hesketh et al., Antiemetics: ASCO Guideline Update, J Clin Oncol 2020
What the Haematology & Oncology exam covers
The blueprint groups questions into these domains. Weight your revision the same way - the heavier domains carry more of your score.
Red Cell Disorders and Anaemias
~14%Iron deficiency and anaemia of inflammation · Vitamin B12 and folate deficiency · Autoimmune haemolytic anaemia
Haemoglobinopathies and Transfusion Medicine
~12%Sickle cell disease · Thalassaemia trait and major · ABO incompatibility and acute haemolytic reactions
Haemostasis and Thrombosis
~14%Interpretation of PT, APTT and mixing studies · Haemophilia A and B · Von Willebrand disease
Myeloid Malignancies
~10%Acute myeloid leukaemia · Acute promyelocytic leukaemia and differentiation syndrome · Chronic myeloid leukaemia and TKI monitoring
Lymphoid Malignancies and Plasma Cell Disorders
~12%Hodgkin lymphoma · Diffuse large B-cell lymphoma and anti-CD20 therapy · Burkitt and other high-grade lymphomas
Solid Tumour Oncology
~16%Breast cancer · HER2-targeted therapy and cardiac monitoring · Colorectal cancer
Systemic Anticancer Therapy and Supportive Care
~10%Neutropenic sepsis management · Chemotherapy toxicities · Antiemetic prophylaxis by emetic risk
Oncological Emergencies
~7%Metastatic spinal cord compression · Tumour lysis syndrome · Hypercalcaemia of malignancy
Stem Cell Transplantation and Professional Practice
~5%Indications for autologous and allogeneic transplant · Graft-versus-host disease · Infection prophylaxis after transplant
How to answer these questions
Read the last line of the stem first, then the vignette: you will know whether it asks for a diagnosis, the next investigation or the next step in management.
"Most appropriate next step" means the next thing you would actually do, in order - stabilise, then confirm, then treat.
Specialist papers lean on current international guidelines; when an option sounds outdated, it usually is.
Aim to score comfortably above your regulator's pass mark - 10 to 15 points of margin - on timed, full-length practice before you book.
The full Haematology & Oncology bank: from 3 papers, ~150 questions each
AED 319 one-time
Every question with a rationale and a reference. PDF, lifetime access.
Tell us your authority and we send the bank for that exam, usually the same day.
Haematology & Oncology exam questions: FAQs
How many questions are in the Haematology & Oncology Prometric exam?
What is the pass mark for the Haematology & Oncology exam?
Are these real exam questions?
Is the Haematology & Oncology exam the same in every GCC country?
How should I use these questions?
Last reviewed September 2026. Questions are original and written to the published exam blueprint; they are not taken from any real paper.
More free exam questions
Pass the Haematology & Oncology exam first time
Not sure which regulator's exam you need, or whether you are exempt? Tell us your profession and target country - we confirm your route and the exact exam before you book.